Cargando…

Efficacy and safety of pinaverium bromide combined with flupentixol-melitracen for diarrhea-type irritable bowel syndrome: A systematic review and meta-analysis

BACKGROUND: There are many trials on the combination of Pinaverium bromide (PB) and Flupentixol-melitracen (FM) in the treatment of diarrhea-type irritable bowel syndrome (IBS-D), but the sample sizes are small, and the research conclusions are inconsistent. Thus, a meta-analysis was performed, aimi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Lifeng, Qin, Jinmei, Yang, Qian, Lv, Xiaoping, Huang, Liyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336559/ https://www.ncbi.nlm.nih.gov/pubmed/30633208 http://dx.doi.org/10.1097/MD.0000000000014064

Ejemplares similares

Melitracen and flupentixol (deanxit) use disorder in Lebanon
por: El Zahran, Tharwat, et al.
Publicado: (2023)

Case report: Extrapontine myelinolysis combined with flupentixol- and melitracen-induced dysphagia
por: Zhao, Zhihong, et al.
Publicado: (2023)

The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis
por: Zhou, Xiaoqian, et al.
Publicado: (2019)

Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis
por: Bor, Serhat, et al.
Publicado: (2021)

Clinical efficacy of cognitive behavioral therapy combined with pinaverium bromide tablets on irritable bowel syndrome
por: Liu, Quanxi, et al.
Publicado: (2023)

Comparison of acupuncture and pinaverium bromide in the treatment of irritable bowel syndrome: A protocol for systematic review and meta-analysis
por: Li, Huaiyu, et al.
Publicado: (2021)

Improvement of Quality of Nonanesthetic Colonoscopy by Preoperative Administration of Pinaverium Bromide
por: Wang, Xiao-Lin, et al.
Publicado: (2017)

Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial
por: Schmulson, Max J., et al.
Publicado: (2020)

Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions
por: Wu, Lihua, et al.
Publicado: (2019)

In Vitro Inhibition of Growth, Biofilm Formation, and Persisters of Staphylococcus aureus by Pinaverium Bromide
por: Mao, Ting, et al.
Publicado: (2023)

Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial
por: Zheng, Liang, et al.
Publicado: (2021)

Flupentixol tartrate
por: Yamuna, Thammarse S., et al.
Publicado: (2014)

Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis
por: Clavé, Pere, et al.
Publicado: (2017)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review
por: Triantafillidis, John K, et al.
Publicado: (2014)

Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome
por: Chiba, Toshimi, et al.
Publicado: (2013)

Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial
por: Lee, Jin-Hyun, et al.
Publicado: (2019)

Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome
por: Zhan, Kai, et al.
Publicado: (2020)

Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Jing, et al.
Publicado: (2020)

The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome
por: Chang, Full-Young, et al.
Publicado: (2011)

Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China
por: Hou, Xiaohua, et al.
Publicado: (2014)

Efficacy and dose response of Lactiplantibacillus plantarum in diarrhea-predominant irritable bowel syndrome
por: Martoni, Christopher J, et al.
Publicado: (2023)

Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial
por: Anderle, Karolina, et al.
Publicado: (2022)

Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis
por: Guo, Jianbo, et al.
Publicado: (2020)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea
por: Ida, Motoko, et al.
Publicado: (2017)

Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
por: Sciumè, Giusi Desirè, et al.
Publicado: (2023)

Is Otilonium Bromide Really Effective for Treating Asian Patients With Irritable Bowel Syndrome?
por: Kim, Ji Won
Publicado: (2012)

Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial
por: Fukushima, Yasushi, et al.
Publicado: (2012)

The management challenges of a case with Flupentixol‐induced neuroleptic malignant syndrome
por: Elyasi, Forouzan, et al.
Publicado: (2022)

Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
por: Luo, Mei, et al.
Publicado: (2022)

Long-term effect of moxibustion on irritable bowel syndrome with diarrhea: a randomized clinical trial
por: Bao, Chunhui, et al.
Publicado: (2022)

Moxibustion treatment for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial
por: Bao, Chunhui, et al.
Publicado: (2016)

Efficacy and safety of lactulose for the treatment of irritable bowel syndrome
por: Chen, Hong-Bin, et al.
Publicado: (2019)

Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
por: Fragkos, Konstantinos C
Publicado: (2017)

Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
por: Andrews, Christopher N, et al.
Publicado: (2019)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

Bromide of Potassium in Convulsions and Dental Irritation
Publicado: (1874)

Cannot write session to /tmp/vufind_sessions/sess_e0fpbumk7qafr1dei1srkcvvj7